Michael Ecke is a mortgage professional - NMLS # 1439805, entrepreneur, businessman, and founder of Prosperment. As a current employee of a Fortune 50 company, Michael is dedicated to ensuring the utmost attention to detail and quality control. Michael provides executive oversight and direction to Prosperment and its sister companies. Michael brings to his position the business foresight and acumen required as Prosperment continues its remarkable growth.
NYSE | TSX : ACB
Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) announced on 10/25/2018 that Polish Ministry of Health granted the Company approval for its first shipment of medical cannabis to Poland. In the coming days, Aurora Deutschland GmbH will ship the products to a pain treatment center and a hospital in Warsaw, Poland. This is an important milestone for medical patients in Poland, as it is believed to be the first time a non-government run business has been granted approval to supply medical cannabis products in the country.
Aurora Supplies Poland with Medical Cannabis
Under Polish legislation, physicians can prescribe medical cannabis products to patients who can then access it through registered pharmacies. In specific instances, products will be covered under statutory health insurance, thus establishing a new and significant medical market for Aurora.
"Becoming the first company to supply cannabis to Poland is validation of Aurora's ability to do business in international markets with high barriers to entry," said Neil Belot, Chief Global Business Development Officer. "This is an important milestone for patient access in Poland, which will provide options for people seeking alternative medications to help manage symptoms of a wide range of medical conditions. Aurora continues to grow its international footprint, which now spans 19 countries on five continents, and puts us in an enviable position to capitalize on our early mover advantage."
Maximilian Weinberg, Head of Business Development, Aurora Europe, added, "We are thrilled to have successfully navigated the complexities of the Polish regulatory framework, and are proud to become the first company to supply a Polish hospital with medical cannabis. Throughout this process we've established strong relationships with medical professionals, state-owned wholesalers, and local foundations who have played an integral role in achieving this milestone."
Medical Cannabis was legalized in Poland in 2017. The current population in Poland is approximately 37.97 million.
About Aurora Cannabis Inc.
With a current funded capacity of 430,000 kg per year, increasing to over 570,000 kg per year upon the successful closing of the MedReleaf acquisition, Aurora is one of the world's largest and fastest growing cannabis companies.
Aurora has created a growing constellation of subsidiaries and strategic partnerships that provide differentiation in terms of geographic reach, production, technology, product offering, and execution.
With a growing number of countries adopting medical cannabis legislation, the Company has embarked on an aggressive international expansion strategy that currently sees Aurora with operations and/or sales and participations in Germany, Denmark, Italy and Australia.
Promotion: Get $5 for Joining Stash Invest